Lantern Pharma (LTRN) Net Shares Issued and Repurchased (2021 - 2024)
Lantern Pharma's (LTRN) quarterly Net Shares Issued and Repurchased came in at $33904.0 in Q1 2024, down 69.32% quarter-over-quarter from $110500.0 in Q4 2021.
Powered by 
Analysis
Lantern Pharma (LTRN) Net Shares Issued and Repurchased (2021 - 2024) Analysis & Trends
Lantern Pharma (LTRN) has reported Net Shares Issued and Repurchased for 2 consecutive years, with $33904.0 the latest figure, recorded in Q1 2024.
- For the quarter ending Q1 2024, Net Shares Issued and Repurchased changed N/A year-over-year to $33904.0; the trailing twelve-month figure through Mar 2024 stood at $33904.0 (changed N/A YoY), and the FY2021 full-year result was $110500.0, changed N/A from the prior year.
- Net Shares Issued and Repurchased slipped to $33904.0 in Q1 2024 per LTRN's latest filing, from $110500.0 in the prior quarter.
- Across five years, Net Shares Issued and Repurchased topped out at $110500.0 in Q4 2021 and bottomed at $33904.0 in Q1 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | Lantern Pharma | 21.99 Mn | 21.99 Mn | - | - |